|
| ONGOING CLINICAL RESEARCH
RELATED TO LYMPHOMA
|
|
CTRI/2009/091/000566
Department:
Oncology
Disease Condition:
Patients with Diffuse Large B-Cell Lymphoma following Autologous Stem Cell Transplantation
Study Title:
Treatment of patients with Aggressive Lymphoma following Self Stem Cell Transplantation
Phase of Trial:
Phase-2
Status of Trial:
Open to recruitment
Click here to register your patient detail
|
|
CTRI/2009/091/000743
Department:
Oncology
Disease Condition:
Follicular Lymphoma
Study Title:
Phase 2 Study of VELCADE With Fludarabine in Comparison to Rituximab With Fludarabine in Follicular Lymphoma Patients Previously Treated With Rituximab
Phase of Trial:
Phase-2
Status of Trial:
Open to recruitment
Click here to register your patient detail
|
|
CTRI/2009/091/000771
Department:
Pharmacology
Disease Condition:
Mantle Cell Lymphoma
Study Title:
A phase II trial to study the efficacy and safety of a new drug P276-00 in the treatment of Mantle Cell Lymphoma
Phase of Trial:
Phase-2
Status of Trial:
Open to recruitment
Click here to register your patient detail
|
|
Here is the latest list of Ongoing
Clinical Research in India. Please Select the appropriate department to get the
list of diseases for which patients recruitment is being undertaken as of now.
In case you are interested in enrolling for any of these trials,kindly send us a
mail on : [email protected] and we shall send you the requisite details.
|
| If you are a Physician / Doctor interested in registering your details with us
Click Here
|
|
|
|
|
|
|
| On Going Clinical trials: Dental, Cardiology, Neurology, Ophthalmology, Assisted Reproduction, Nephrology , General surgery,Orthopaedics, Laproscopy
Surgery, Oncology, Endocrinology, Dermatology/Skin, Rehabilitation, Genetic Medicine, Ophthalmology, Paediatrics - Medicine, Gynaecology & Obstetrics, Neurosurgery, Pathology Venerology Immunology Algology (Pain Management) Pharmacology Hepatology Diabetology Anaesthesiology Yoga Psychiatry |
 |
 |
|
|
.........................................................................................................................................